PAVmed, Inc. (PAVM)
5.28
+0.19
(+3.73%)
USD |
NASDAQ |
Sep 04, 16:00
5.20
-0.08
(-1.52%)
After-Hours: 20:00
PAVmed SG&A Expense (TTM) : 20.09M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.09M |
| March 31, 2026 | 19.11M |
| December 31, 2025 | 17.17M |
| September 30, 2025 | 16.57M |
| June 30, 2025 | 22.43M |
| March 31, 2025 | 29.79M |
| December 31, 2024 | 36.15M |
| September 30, 2024 | 43.53M |
| June 30, 2024 | 44.84M |
| March 31, 2024 | 44.58M |
| December 31, 2023 | 48.14M |
| September 30, 2023 | 52.24M |
| June 30, 2023 | 56.42M |
| March 31, 2023 | 62.17M |
| December 31, 2022 | 61.01M |
| September 30, 2022 | 54.66M |
| June 30, 2022 | 45.59M |
| March 31, 2022 | 35.59M |
| December 31, 2021 | 26.95M |
| September 30, 2021 | 21.40M |
| June 30, 2021 | 18.32M |
| March 31, 2021 | 14.47M |
| December 31, 2020 | 12.33M |
| Date | Value |
|---|---|
| September 30, 2020 | 10.75M |
| June 30, 2020 | 9.564M |
| March 31, 2020 | 8.597M |
| December 31, 2019 | 7.665M |
| September 30, 2019 | 7.272M |
| June 30, 2019 | 6.945M |
| March 31, 2019 | 6.622M |
| December 31, 2018 | 6.310M |
| September 30, 2018 | 5.702M |
| June 30, 2018 | 5.568M |
| March 31, 2018 | 5.297M |
| December 31, 2017 | 5.415M |
| September 30, 2017 | 5.186M |
| June 30, 2017 | 5.273M |
| March 31, 2017 | 4.913M |
| December 31, 2016 | 3.931M |
| September 30, 2016 | 3.417M |
| June 30, 2016 | 2.341M |
| March 31, 2016 | 1.675M |
| December 31, 2015 | 1.287M |
| September 30, 2015 | 0.6979M |
| June 30, 2015 | 0.4235M |
| March 31, 2015 | 0.1303M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Abbott Laboratories | 13.94B |
| AngioDynamics, Inc. | 157.09M |
| Alphatec Holdings, Inc. | 524.06M |
| AtriCure, Inc. | 323.68M |
| Baxter International, Inc. | 2.932B |